2BB score and signals
CG Oncology, Inc.’s current 2BB score is 46 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 64 | High |
| Momentum | 51 | Stable |
| Financial strength | 39 | Weak |
| Quality | 100 | Very Strong |
| Risk | 40 | Low |
Company facts
| Headquarters | Dallas, Texas, United States |
| Founded | 2010 |
| Employees | 142 |
| 52-week range | $26.24 – $80.97 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-25 | — | -0.8513 | — | $594,150.00 |
| 2026-11-12 | — | -0.8348 | — | $544,853.00 |
| 2026-08-07 | — | -0.6776 | — | $367,628.00 |
| 2026-05-08 | -0.71 | -0.5771 | $1.08M | $503,043.00 |
Related companies
